555 related articles for article (PubMed ID: 7732382)
1. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin.
Fenteany G; Standaert RF; Lane WS; Choi S; Corey EJ; Schreiber SL
Science; 1995 May; 268(5211):726-31. PubMed ID: 7732382
[TBL] [Abstract][Full Text] [Related]
2. Specific inhibition of the chymotrypsin-like activity of the proteasome induces a bipolar morphology in neuroblastoma cells.
Fenteany G; Schreiber SL
Chem Biol; 1996 Nov; 3(11):905-12. PubMed ID: 8939705
[TBL] [Abstract][Full Text] [Related]
3. Lactacystin and clasto-lactacystin beta-lactone modify multiple proteasome beta-subunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation.
Craiu A; Gaczynska M; Akopian T; Gramm CF; Fenteany G; Goldberg AL; Rock KL
J Biol Chem; 1997 May; 272(20):13437-45. PubMed ID: 9148969
[TBL] [Abstract][Full Text] [Related]
4. Lactacystin, proteasome function, and cell fate.
Fenteany G; Schreiber SL
J Biol Chem; 1998 Apr; 273(15):8545-8. PubMed ID: 9535824
[No Abstract] [Full Text] [Related]
5. Mechanistic studies on the inactivation of the proteasome by lactacystin: a central role for clasto-lactacystin beta-lactone.
Dick LR; Cruikshank AA; Grenier L; Melandri FD; Nunes SL; Stein RL
J Biol Chem; 1996 Mar; 271(13):7273-6. PubMed ID: 8631740
[TBL] [Abstract][Full Text] [Related]
6. The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up- or down-regulate antigen presentation at nontoxic doses.
Schwarz K; de Giuli R; Schmidtke G; Kostka S; van den Broek M; Kim KB; Crews CM; Kraft R; Groettrup M
J Immunol; 2000 Jun; 164(12):6147-57. PubMed ID: 10843664
[TBL] [Abstract][Full Text] [Related]
7. The proteasome as a lipopolysaccharide-binding protein in macrophages: differential effects of proteasome inhibition on lipopolysaccharide-induced signaling events.
Qureshi N; Perera PY; Shen J; Zhang G; Lenschat A; Splitter G; Morrison DC; Vogel SN
J Immunol; 2003 Aug; 171(3):1515-25. PubMed ID: 12874245
[TBL] [Abstract][Full Text] [Related]
8. The 20S proteasome of Streptomyces coelicolor.
Nagy I; Tamura T; Vanderleyden J; Baumeister W; De Mot R
J Bacteriol; 1998 Oct; 180(20):5448-53. PubMed ID: 9765579
[TBL] [Abstract][Full Text] [Related]
9. Lactacystin, a specific inhibitor of the proteasome, inhibits human platelet lysosomal cathepsin A-like enzyme.
Ostrowska H; Wojcik C; Omura S; Worowski K
Biochem Biophys Res Commun; 1997 May; 234(3):729-32. PubMed ID: 9175783
[TBL] [Abstract][Full Text] [Related]
10. Lactacystin, a proteasome inhibitor: discovery and its application in cell biology.
Tomoda H; Omura S
Yakugaku Zasshi; 2000 Oct; 120(10):935-49. PubMed ID: 11082705
[TBL] [Abstract][Full Text] [Related]
11. Proteasomes can either generate or destroy MHC class I epitopes: evidence for nonproteasomal epitope generation in the cytosol.
Luckey CJ; King GM; Marto JA; Venketeswaran S; Maier BF; Crotzer VL; Colella TA; Shabanowitz J; Hunt DF; Engelhard VH
J Immunol; 1998 Jul; 161(1):112-21. PubMed ID: 9647214
[TBL] [Abstract][Full Text] [Related]
12. Components of the bovine pituitary multicatalytic proteinase complex (proteasome) cleaving bonds after hydrophobic residues.
Cardozo C; Michaud C; Orlowski M
Biochemistry; 1999 Jul; 38(30):9768-77. PubMed ID: 10423257
[TBL] [Abstract][Full Text] [Related]
13. Dual roles of proteasome in the metabolism of presenilin 1.
Honda T; Yasutake K; Nihonmatsu N; Mercken M; Takahashi H; Murayama O; Murayama M; Sato K; Omori A; Tsubuki S; Saido TC; Takashima A
J Neurochem; 1999 Jan; 72(1):255-61. PubMed ID: 9886077
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic studies on the inactivation of the proteasome by lactacystin in cultured cells.
Dick LR; Cruikshank AA; Destree AT; Grenier L; McCormack TA; Melandri FD; Nunes SL; Palombella VJ; Parent LA; Plamondon L; Stein RL
J Biol Chem; 1997 Jan; 272(1):182-8. PubMed ID: 8995245
[TBL] [Abstract][Full Text] [Related]
15. Proteasome inhibitors block development of Plasmodium spp.
Gantt SM; Myung JM; Briones MR; Li WD; Corey EJ; Omura S; Nussenzweig V; Sinnis P
Antimicrob Agents Chemother; 1998 Oct; 42(10):2731-8. PubMed ID: 9756786
[TBL] [Abstract][Full Text] [Related]
16. Lactacystin, a specific inhibitor of the proteasome, induces apoptosis in human monoblast U937 cells.
Imajoh-Ohmi S; Kawaguchi T; Sugiyama S; Tanaka K; Omura S; Kikuchi H
Biochem Biophys Res Commun; 1995 Dec; 217(3):1070-7. PubMed ID: 8554559
[TBL] [Abstract][Full Text] [Related]
17. Lactacystin increases LDL receptor level on HepG2 cells.
Miura H; Tomoda H; Miura K; Takishima K; Omura S
Biochem Biophys Res Commun; 1996 Oct; 227(3):684-7. PubMed ID: 8885994
[TBL] [Abstract][Full Text] [Related]
18. Covalent modification of the active site threonine of proteasomal beta subunits and the Escherichia coli homolog HslV by a new class of inhibitors.
Bogyo M; McMaster JS; Gaczynska M; Tortorella D; Goldberg AL; Ploegh H
Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6629-34. PubMed ID: 9192616
[TBL] [Abstract][Full Text] [Related]
19. c-Jun N-terminal kinase pathway mediates Lactacystin-induced cell death in a neuronal differentiated Neuro2a cell line.
Sang C; Kobayashi Y; Du J; Katsumo M; Adachi H; Doyu M; Sobue G
Brain Res Mol Brain Res; 2002 Dec; 108(1-2):7-17. PubMed ID: 12480174
[TBL] [Abstract][Full Text] [Related]
20. Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity.
Meng L; Mohan R; Kwok BH; Elofsson M; Sin N; Crews CM
Proc Natl Acad Sci U S A; 1999 Aug; 96(18):10403-8. PubMed ID: 10468620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
